Tata Capital Growth Fund to Invest USD30m in Indian Biopharma Biocon Biologics for 0.85% Stake
Source(s): Biocon Biologics
Tata Capital Growth Fund has agreed to invest INR2.25b (approximately USD30m) in India-based biopharmaceuticals company Biocon Biologics for a 0.85% stake in a deal that reportedly values the business at USD3.5b. Read more